echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Related: Comparison of cardiovascular toxicity between cigarettes and e-cigarettes in adults

    Related: Comparison of cardiovascular toxicity between cigarettes and e-cigarettes in adults

    • Last Update: 2021-01-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Smoking is a major cause of noncommunicable diseases worldwide and a major risk factor for lung disease.
    despite the dramatic decline in global tobacco use over the past two decades, the use of e-cigarettes and sedgeum remains an emerging trend, especially among the younger generation.
    Since the introduction of E-cigarettes in 2005, the global e-cigarette epidemic has risen sharply, with e-cigarette sales growing almost dozens of times over the past decade, showing a "pandemic" trend, especially among the younger generation since 2016.
    the global e-cigarette market will exceed $60 billion between 2020 and 2025, according to market intelligence firm Arizton.
    e-cigarettes are typical forms of an e-nicotine delivery system that vaporizes nicotine-containing liquids for inhalation purposes.
    , however, there is growing evidence that e-cigarettes are not harmless substitutes for tobacco.
    including last year's outbreak in the United States of America of "lung damage caused by the use of e-cigarettes or e-atomization products" (EVALI) to increase the likely infection of new coronary pneumonia, suggest that e-cigarettes may be a significant health risk.
    Evali patients with symptom attacks and hospitalizations, the CDC so, given that inflammation and oxidative stress are key factors in smoking-induced cardiovascular disease, e-cigarettes can also cause increased levels of inflammation and oxidative stress biomarkers in the human body? Which is more cardiovascularly toxic than regular cigarettes? To that end, a team of researchers from Johns Hopkins and Boston University in the United States studied the issue.
    results were published in the latest issue of circulation in the form ofLetter.
    path (Tobacco and Healthy Population Assessment) study is the most nationally representative longitudinal queue in the United States.
    first survey was conducted in 2013-2014 and included the collection of blood and urine samples.
    the study, the researchers' analysis was limited to adults aged ≥18 in the first study, including data on biomarkers and cigarette/e-cigarette use in that group.
    The participants were divided into four groups based on their use of cigarettes/e-cigarettes over the past 30 days: (1) not using cigarettes or e-cigarettes;
    detected inflammatory biomarkers (hs-CRP, IL-6, fibrinogen, soluble intercellular adhesion molecules) and oxidative stress factors (urine 8-isoarthrogen).
    corrects covariating variables that may affect smoking behavior, including race, gender, age, education, family income, body mass index, combined diabetes, heart disease, heart failure, stroke, use of other tobacco products, drug use, etc.
    the relationship between cigarette/e-cigarette use and biomarkers using corrected multi-factor linear analysis models.
    results included 7,130 participants, of whom 58.6 per cent did not smoke cigarettes/e-cigarettes, 1.9 per cent and 29.6 per cent used e-cigarettes only for cigarettes, and 9.9 per cent used both.
    multi-factor linear regression model showed no difference between inflammatory and oxidative stress markers between participants who used e-cigarettes and non-smokers.
    , but compared to those who did not smoke anything, both used significantly higher levels of inflammation and oxidative stress markers in the population.
    further analysis showed that participants who used e-cigarettes only had higher hs-CRP and lower other factors than those who used only cigarettes.
    that there was no difference in factor indicators between users of the two products and users of a specific cigarette.
    , the results of other tobacco substitutes are similar.
    , there was no difference in inflammation and oxidative stress biomarkers among e-cigarette and non-smoking participants in the nationally representative adult population study.
    e-cigarette smokers had lower levels of inflammation and oxidative stress markers than cigarette smokers.
    the importance of replacing cigarettes entirely with e-cigarettes or quitting smoking entirely.
    , in the author's view, in view of the above and previous research results, do not smoke any tobacco products is undoubtedly the best choice.
    : Stokes AC, et al. Association of Cigarette and Electronic Cigarette Use Patterns With Levels of Inflammatory and Oxidative Stress Biomarkers Among US Adults: Population Assessment of Tobacco and Health Study. Circulation. 2021 Jan 4. doi: 10.1161/REPORTAHA.120.051551.MedSci Original Source: MedSci Original Copyright Notice: All noted on this website "Source: Mays Medicine" or "Source: MedSci Original" text, images and audio and video materials, copyrights are owned by Metz Medicine, without authorization, no media, website or individual may reproduce, authorized to reproduce with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    reproduce content at the same time does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.